Protein Structural Biology In Biomedical Research. Advances In Molecular And Cell Biology, Volume 22 – Video


Protein Structural Biology In Biomedical Research. Advances In Molecular And Cell Biology, Volume 22
ll4.me Protein Structural Biology In Biomedical Research. Advances In Molecular And Cell Biology, Volume 22b. Recent advances in protein structural biology, coupled with new developments in human genetics, have opened the door to understanding the molecular basis of many metabolic, physiological, and developmental processes in human biology. Medical pathologies, and their chemical therapies, are increasingly being described at the molecular level. For single-gene diseases, and some multi-gene conditions, identification of highly correlated genes immediately leads to identification of covalent structures of the actual chemical agents of the disease, namely the protein gene products. Once the primary sequence of a protein is ascertained, structural biologists work to determine its three-dimensional, biologically active structure, or to predict its probable fold and/or function by comparison to the data base of known protein structures. Similarly, three-dimensional structures of proteins produced by microbiological pathogens are the subject of intense study, for example, the proteins necessary for maturation of the human HIV virus. Once the three-dimensional structure of a protein is known or predicted, its function, as well as potential binding sites for drugs that inhibit its function, become tractable questions. The medical ramifications of the burgeoning results of protein structural biology, from gene replacement therapy to rational drug design, are well recognized by ...From:ashleygibbons986Views:0 0ratingsTime:00:14More inPeople Blogs

More here:

Protein Structural Biology In Biomedical Research. Advances In Molecular And Cell Biology, Volume 22 - Video

Growth Hormone – Video


Growth Hormone
ll4.me Growth Hormone Introduction.- Placenta and early embryonic development.- Experimental models.- Evolution, aging, life span.- Brain development.- Development of sensory organs.- Neuroplasticity and neuroprotection.- Reproductive tract.- Skeletal muscle.- Cardiovascular system-lung.- Hematopoiesis.- Pancreas development and glucose regulation.- IGF interaction with other trophic factors.- Cancer.- Human genetics of the GH-IGF-I axis.- Future perspectives-stem cells.- Index EAN/ISBN : 9780387262741 Publisher(s): Springer, Berlin, Springer US Discussed keywords: Wachstumshormon Format: ePub/PDF Author(s): Varela-Nieto, Isabel - Chowen, Julie A. Introduction.- Placenta and early embryonic development.- Experimental models.- Evolution, aging, life span.- Brain development.- Development of sensory organs.- Neuroplasticity and neuroprotection.-From:lamarpalmer654Views:0 0ratingsTime:00:14More inPeople Blogs

Read the original:

Growth Hormone - Video

GHOST ISLAND (The Hidden) – Video


GHOST ISLAND (The Hidden)
#9658; #9658; #9658; Enjoy the video? Subscribe! bit.ly #9668; #9668; #9668; Download Here: http://www.hidden-source.com What is The Hidden? "In the early 1950s human genetics experimentation was taking its first, tentative steps. Amongst many other black projects, a team of British scientists working at an Infinitum Research experimental station stumbled across some remarkable phenomena involving DNA manipulation. This led to deeper research with dangerously unpredictable results, often leading to human patients losing their lives in irresponsible and immoral experiments. Time passed on, and by the mid 1990s the failure rate of the experiments had been reduced from 75% to a mere 15%, enough for Infinitum to move onto the next stage Biological Light Refraction. The British team were hoping to unravel the possibilities of light manipulation to create the perfect covert military agent. Early into the new millennium, due to a gross miscalculation, a series of tests on Subject 617 led to a massive synaptic trauma leaving the patient with multiple genetic anomalies. The subject was left in constant pain and with unstable DNA. The subject escaped captivity, killing anyone that got in its way. The IRIS (Infinitum Research Interception Squad) team have been deployed to return the subject to a maximum security Infinitum Research facility for further study and dissection. The entire project was considered a failure: all funding ceased and development was discontinued while all records and traces of the experiments ...From:SeaNannersViews:279982 9717ratingsTime:03:17More inGaming

Link:

GHOST ISLAND (The Hidden) - Video

The Hidden – (Fart Grenades And Friendly Fire) – Video


The Hidden - (Fart Grenades And Friendly Fire)
#9689; #9689; #9689; #9658;Did you like the video? Why not Subscribe! bit.ly #9689; #9689; #9689; #9658;If you enjoy why not leave a like/comment and let me know? #9668; #9689; #9689; #9689; In the early 1950s human genetics experimentation was taking its first, tentative steps. Amongst many other black projects, a team of British scientists working at an Infinitum Research experimental station stumbled across some remarkable phenomena involving DNA manipulation. This led to deeper research with dangerously unpredictable results, often leading to human patients losing their lives in irresponsible and immoral experiments. Time passed on, and by the mid 1990s the failure rate of the experiments had been reduced from 75% to a mere 15%, enough for Infinitum to move onto the next stage: Biological Light Refraction. The British team were hoping to unravel the possibilities of light manipulation to create the perfect covert military agent. Early into the new millennium, due to a gross miscalculation, a series of tests on Subject 617 led to a massive synaptic trauma leaving the patient with multiple genetic anomalies. The subject was left in constant pain and with unstable DNA. The subject escaped captivity, killing anyone that got in its way. The IRIS (Infinitum Research Interception Squad) team have been deployed to return the subject to a maximum security Infinitum Research facility for further study and dissection. The entire project was considered a failure: all funding ceased and development was discontinued while all records and ...From:Dustin RushViews:15 1ratingsTime:17:59More inGaming

See the original post here:

The Hidden - (Fart Grenades And Friendly Fire) - Video

GHOST ISSUES (The Hidden) – Video


GHOST ISSUES (The Hidden)
Download: grabups.com "In the early 1950s human genetics experimentation was taking its first, tentative steps. Amongst many other black projects, a team of British scientists working at an Infinitum Research experimental station stumbled across some remarkable phenomena involving DNA manipulation. This led to deeper research with dangerously unpredictable results, often leading to human patients losing their lives in irresponsible and immoral experiments. Time passed on, and by the mid 1990s the failure rate of the experiments had been reduced from 75% to a mere 15%, enough for Infinitum to move onto the next stage: Biological Light Refraction. The British team were hoping to unravel the possibilities of light manipulation to create the perfect covert military agent. Early into the new millennium, due to a gross miscalculation, a series of tests on Subject 617 led to a massive synaptic trauma leaving the patient with multiple genetic anomalies.From:bifurcarsb05Views:2 0ratingsTime:03:21More inGaming

Here is the original post:

GHOST ISSUES (The Hidden) - Video

The Hidden – (Blood For The Blood God, I Must Feed) – Video


The Hidden - (Blood For The Blood God, I Must Feed)
#9689; #9689; #9689; #9658;Did you like the video? Why not Subscribe! bit.ly #9689; #9689; #9689; #9658;If you enjoy why not leave a like/comment and let me know? #9668; #9689; #9689; #9689; In the early 1950s human genetics experimentation was taking its first, tentative steps. Amongst many other black projects, a team of British scientists working at an Infinitum Research experimental station stumbled across some remarkable phenomena involving DNA manipulation. This led to deeper research with dangerously unpredictable results, often leading to human patients losing their lives in irresponsible and immoral experiments. Time passed on, and by the mid 1990s the failure rate of the experiments had been reduced from 75% to a mere 15%, enough for Infinitum to move onto the next stage: Biological Light Refraction. The British team were hoping to unravel the possibilities of light manipulation to create the perfect covert military agent. Early into the new millennium, due to a gross miscalculation, a series of tests on Subject 617 led to a massive synaptic trauma leaving the patient with multiple genetic anomalies. The subject was left in constant pain and with unstable DNA. The subject escaped captivity, killing anyone that got in its way. The IRIS (Infinitum Research Interception Squad) team have been deployed to return the subject to a maximum security Infinitum Research facility for further study and dissection. The entire project was considered a failure: all funding ceased and development was discontinued while all records and ...From:Dustin RushViews:1 0ratingsTime:19:06More inGaming

Continued here:

The Hidden - (Blood For The Blood God, I Must Feed) - Video

Evening with the UC Davis Genome Center – Oct 6, 2012 – David Segal – Video


Evening with the UC Davis Genome Center - Oct 6, 2012 - David Segal
Modern human genetics and genomics are revolutionizing biology, medicine, and society. Genomic technology is now advancing faster than computer technology. The day is rapidly approaching when individuals will be able to obtain their entire personal genetic sequence. Is society ready? Should we have access to this information? While it may inform us of our susceptibility to some diseases much earlier, will it improve health or simply reveal our fate? At this Evening with the UC Davis Genome Center event David Segal, addresses these timely questions and discusses the potential impact that this new technology could have on public health, as well as some ways this information can be used and protected.From:David SegalViews:2 0ratingsTime:01:00:58More inScience Technology

Read this article:

Evening with the UC Davis Genome Center - Oct 6, 2012 - David Segal - Video

David Icke: Human Genetics, The Religion of Death – Video


David Icke: Human Genetics, The Religion of Death
Alex talks with author and presenter David Icke about election fraud and human genetics. http://www.davidicke.com ORDER THIS SURVIVAL DVD AND START GETTING PREPARED TODAY AT... http://www.infowarsshop.com Joel Skousen sits down with Alex Jones and discusses strategies on how to prepare for and survive major disasters. http://www.infowars.com http://www.prisonplanet.tv twitter.com http://www.facebook.com [Join The Alex Jones Team and Start Getting Healthy Today!] http://www.infowarsteam.com Get all your Youngevity Products such as Beyond Tangy Tangerine, the Alex Pack and Pollen Burst. These supplements are a great way to get your essentials vitamins, minerals, amino acids, and other beneficial nutrients [[[ProPur Water Filtration]]] http://www.infowarsshop.comFrom:TheAlexJonesChannelViews:8627 245ratingsTime:58:00More inPeople Blogs

See the rest here:

David Icke: Human Genetics, The Religion of Death - Video

David Icke – Infowars Election Coverage 2012 – Video


David Icke - Infowars Election Coverage 2012
Alex Jones talks with author and presenter David Icke about election fraud and human genetics. http://www.davidicke.com http://www.infowars.com prisonplanet.tv conspiracyscope.blogspot.com http://www.youtube.comFrom:ConspiracyScopeViews:518 13ratingsTime:58:00More inNews Politics

Read more:

David Icke - Infowars Election Coverage 2012 - Video

Ingenuity Variant Analysis Sees Exponential Customer Adoption

REDWOOD CITY, Calif., Nov. 6, 2012 /PRNewswire/ --Ingenuity Systems, a leading provider of biomedical information and analysis solutions, today highlighted strong adoption of its Variant Analysis platform at the American Society of Human Genetics Annual Meeting in San Francisco. Variant Analysis, a web-based analysis application, answers a critical need for researchers trying to rapidly identify relevant casual variants in human diseases from re-sequencing data.

Over the past 6 months the number of users and samples uploaded into Ingenuity Variant Analysis has grown 250% month-over-month and today 1,100 users are actively working on whole genome and exome projects ranging from individual genomes to thousands of genomes. The users represent over 500 leading institutions and drug discovery companies studying all stages of basic, translational and clinical research.

"All of us need help interpreting DNA sequence variation in the context of the world's literature and rapidly evolving databases," said David M. Margulies, MD, Executive Director, Gene Partnership, Children's Hospital Boston and member of Faculties of Genetics, Bioinformatics, and Developmental Medicine, Harvard Medical School. "Ingenuity's rigorous methods for curating variant information and its deep capabilities in relating sequence and expression data to underlying pathways are invaluable to us as we seek to understand the contribution of sequence variation to disease in both clinical and discovery scenarios."

"The interpretation of human genomes for medical and biological relevance is a major challenge. Variant Analysis has proven to be a helpful tool to contribute to the interpretation of our exome sequencing-basedstudies," stated Estelle Chanudet-van den Brink, PhD, Senior Research Associate, GOSgene, University College of London. "We tested it in the context of 9 different rare genetic conditions (73 samples total), including variousmodes of inheritance.We found the process intuitive and the analytic parameters pragmatically fitted to the diversity of our data. The access to rich biological content, that leverages information on pathways and disease models, was particularly useful to support the prioritization of variants for further analyses.We are now extending the use of Variant Analysis to additional cohorts of patients (250 samples)."

"Increasing access to the unique content and intuitive graphical user interface in Variant Analysis allowed us to quickly identify variants of interest in our sequencing data on muscular dystrophy," said Susan Dorsey, PhD, RN, FAAN, Associate Dean for Research, University of Maryland."In a matter of hours, we were able to quickly learn how to use the tool and obtain preliminary results.I anticipate that we will be working with the company and its tools for years to come."

Further, at ASHG this week in San Francisco, attendees will have will have the opportunity to demo Variant Analysis in the Ingenuity booth #1101 or through its integration into third-party applications such as Ion Torrent's Ion Reporter and Illumina's BaseSpace.

About Ingenuity SystemsIngenuity Systems is a leading provider of biomedical information and analysis solutionsfor the exploration, interpretation and analysis of complex biological systems inlife science research and molecular diagnostics.Today, Ingenuity's solutions are used by tens of thousands of researchers and clinicians at hundreds of leading pharmaceutical, biotechnology, academic, diagnostic and clinical institutions worldwide.

Go here to see the original:

Ingenuity Variant Analysis Sees Exponential Customer Adoption

Ariosa Diagnostics to Present Clinical Data on the Harmonyâ„¢ Prenatal Test at American Society of Human Genetics Annual …

SAN JOSE, Calif., Nov. 5, 2012 /PRNewswire/ -- Ariosa Diagnostics today announced that it will present data from two recent studies on non-invasive prenatal testing (NIPT) at the American Society of Human Genetics (ASHG) Annual Meeting at The Moscone Center in San Francisco, Calif. from Nov. 6 - 11, 2012. The studies highlight a directed cell-free (cfDNA) analysis method of NIPT.

(Logo: http://photos.prnewswire.com/prnh/20121105/NE05794LOGO)

A poster titled "Non-invasive Chromosomal Evaluation (NICE) Study: Results of a Multicenter, Prospective, Cohort Study for Detection of Fetal Trisomy 21 and Trisomy 18," examines the performance of Ariosa's Harmony Prenatal Test, a directed cfDNA analysis method of detecting fetal trisomies. The NICE study represents the largest cohort study in NIPT. Pregnant women at gestational age 10 weeks or later were enrolled from 50 clinical sites in the U.S. and Europe. The poster will be presented on Thursday, Nov. 8, from 3:15 - 4:15 p.m. PST in The Moscone Center Exhibit Hall, Lower Level South.

A second poster titled "The Fetal Fraction of cell-free DNA in Maternal Plasma is Not Affected by a priori Risk of Fetal Trisomy," examines possible clinical factors that might influence the fetal fraction of cfDNA in maternal plasma. The amount of fetal cfDNA in maternal plasma is a major determinant of the ability to detect trisomy. A comparative analysis shows no difference in fetal cfDNA levels between high- and low-risk pregnant women providing support that NIPT performance will be just as robust in a general pregnancy population. This poster will be presented on Thursday, Nov. 8, from 3:15 - 4:15 p.m. PST in The Moscone Center Exhibit Hall, Lower Level South.

For more information about Ariosa and the company's directed cfDNA analysis method of NIPT, please visit us at Booth #1609.

About Ariosa Diagnostics

Ariosa Diagnostics, Inc., is a molecular diagnostics company committed to innovating together to improve patient care. The flagship product, the Harmony Prenatal Test, is a safe, highly accurate and affordable prenatal test for maternal and fetal health. Led by an experienced team, Ariosa is using its proprietary technology to perform a directed analysis of cell-free DNA in blood. The Harmony test equips pregnant women and their healthcare providers with reliable information to make decisions regarding their health, without creating unnecessary stress or anxiety.

The company began operations in 2010 and is headquartered in San Jose, Calif. For more information, visitwww.ariosadx.com.

Continued here:

Ariosa Diagnostics to Present Clinical Data on the Harmonyâ„¢ Prenatal Test at American Society of Human Genetics Annual ...

DNA sequencing of infants and children with anatomical defects of unknown causes

Public release date: 6-Nov-2012 [ | E-mail | Share ]

Contact: Cathy Yarbrough sciencematter@yahoo.com 858-243-1814 American Society of Human Genetics

A presentation at the American Society of Human Genetics 2012 meeting updated genetics experts about a one-year-old research initiative that brought together researchers, clinicians and policy experts to tackle the challenges of incorporating new genomic technologies into clinical care of newborns, infants and children with anatomical defects whose causes are unknown.

Among the challenges is interpreting how variations in patients' DNA cause or contribute to their medical problems, said Duke University Assistant Professor of Pediatrics Erica E. Davis, Ph.D., who presented the update and is based in the Center for Human Disease Modeling in the university's medical center.

In 2011, the center founded the Duke Task Force for Neonatal Genomics to act as a nucleus for a group of physicians and scientists with the diverse skills sets needed to bridge genetics, genomics, cell biology, ethics and clinical investigation and to offer a "360 degree" view of challenging clinical pediatric cases, Dr. Davis said.

"Strikingly, preliminary analysis of the task force's first year of work has suggested definitive or strong candidate diagnoses in some 90% of the recruited cases," she noted.

During its first year, the task force screened over 150 newborns, infants and children, enrolled 20 patients and developed the capacity to enroll about 100 patients each year.

"Our patients come from the Duke fetal diagnostic center, the Duke intensive care nursery and various pediatric specialty clinics," she said.

In one child with severe epilepsy, the task force used sequencing of the protein-coding regions of the genome (about 2% of the entire human genome) to identify a broken gene that impairs the ability of sodium to move in and out of cells.

"We determined that the child's condition was caused by a new mutation in a gene named SCN2A," Dr. Davis said.

Read more:

DNA sequencing of infants and children with anatomical defects of unknown causes

Surprising findings from NHLBI Exome Sequencing Project reported

Public release date: 6-Nov-2012 [ | E-mail | Share ]

Contact: Cathy Yarbrough press@ashg.org 858-243-1814 American Society of Human Genetics

A multi-institutional team of researchers has sequenced the DNA of 6,700 exomes, the portion of the genome that contains protein-coding genes, as part of the National Heart, Lung and Blood Institute (NHLBI)-funded Exome Sequencing Project, one of the largest medical sequencing studies ever undertaken.

Scientists participating in the project initially expected that individual rare variants would have a greater effect on over 80 heart, lung and blood related traits and diseases of high public health significance, said Suzanne M. Leal, Ph.D., professor and director, Center for Statistical Genetics in the Department of Molecular and Human Genetics of Baylor College of Medicine in Houston, TX.

The researchers found that many (1.1 million) of the 1.2 million coding variants that they identified in exome data from 4,420 European-Americans and 2,312 African-Americans occurred very infrequently in the population and often were only observed in a single individual, explained Dr. Leal, who presented the findings today at the American Society of Human Genetics 2012 meeting.

Dr. Leal added that most of the observed coding variants are population specific, occurring in either European or African Americans. "Of the identified variants, about 720,000 change the genetic code in a manner that could produce flawed proteins. Yet the role played by most of these variants in disease development has not been established," she said.

The major goal of the project was to understand how variation in the exome affects heart, lung and blood related traits and diseases.

The study participants were selected from a sample of over 220,000 individuals who participated in another National Institute of Health (NIH) supported study that had collected extensive medical data on the participants. "Individuals were selected to have a disease endpoint of interest or an extreme trait value of public health importance," said Dr. Leal.

By sequencing the exomes of 91 cystic fibrosis patients, Dr. Leal and her research colleagues discovered and replicated an association between variants in the DCTN4 gene and when a patient first develops a Pseudomonas aeruginosa airway infection.*

The researchers were also able to replicate many known associations between individual DNA variants and traits, such as high blood levels of low-density lipoprotein, known as the 'bad' cholesterol, and C-reactive protein, which increases the body's response to inflammation.

More:

Surprising findings from NHLBI Exome Sequencing Project reported

New method helps link genomic variation to protein production

Public release date: 6-Nov-2012 [ | E-mail | Share ]

Contact: Cathy Yarbrough press@ashg.org 858-243-1814 American Society of Human Genetics

Scientists have adopted a novel laboratory approach for determining the effect of genetic variation on the efficiency of the biological process that translates a gene's DNA sequence into a protein, such as hemoglobin, according to a presentation, Nov. 6, at the American Society of Human Genetics 2012 meeting in San Francisco.

In the 0.1% of the DNA that differs between any two individuals, scientists search for the biological mechanisms underlying human genetic differences, including disease susceptibility.

"How exactly these slight changes in the DNA affect the biology of the human body is not known in most cases," said Constantin Polychronakos, M.D., professor of pediatrics, experimental medicine and human genetics at McGill University, Montreal, Canada.

"We decided to investigate the possibility that some of these changes may alter the translation of RNA into protein, a question that had not been systematically examined before," he added.

Translation is the final stage of gene expression at which the gene's DNA recipe for a protein can be modified, said McGill University scientist Quan Li, Ph.D., who presented the research.

In general, genomic studies have focused on finding links between diseases and variation in DNA. However, the new study takes a big step toward understanding how that variation affects the production of proteins, which are the molecules that most directly affect health and disease.

The study was designed to determine the effect of single-nucleotide polymorphisms (SNPs), which are variations in the DNA sequence, on the process of translation, Dr. Li said.

Translation begins when a gene's DNA sequence is transcribed into the messenger RNA (mRNA) molecule that carries the transcript, or the blueprint for the protein encoded by the gene, to ribosomes, where proteins are manufactured in a cell.

See more here:

New method helps link genomic variation to protein production

Humans, chimpanzees and monkeys share DNA but not gene regulatory mechanisms

Public release date: 6-Nov-2012 [ | E-mail | Share ]

Contact: Cathy Yarbrough press@ashg.org 858-243-1814 American Society of Human Genetics

Humans share over 90% of their DNA with their primate cousins. The expression or activity patterns of genes differ across species in ways that help explain each species' distinct biology and behavior.

DNA factors that contribute to the differences were described on Nov. 6 at the American Society of Human Genetics 2012 meeting in a presentation by Yoav Gilad, Ph.D., associate professor of human genetics at the University of Chicago.

Dr. Gilad reported that up to 40% of the differences in the expression or activity patterns of genes between humans, chimpanzees and rhesus monkeys can be explained by regulatory mechanisms that determine whether and how a gene's recipe for a protein is transcribed to the RNA molecule that carries the recipe instructions to the sites in cells where proteins are manufactured.

In addition to improving scientific understanding of the uniqueness of humans, studies such as the investigation conducted by Dr. Gilad and colleagues could have relevance to human health and disease.

"Through inter-species' comparisons at the DNA sequence and expression levels, we hope to identify the genetic basis of human specific traits and in particular the genetic variations underlying the higher susceptibility to certain diseases such as malaria and cancer in humans than in non-human primates," said Dr. Gilad.

Dr. Gilad and his colleagues studied gene expression in lymphoblastoid cell lines, laboratory cultures of immortalized white blood cells, from eight humans, eight chimpanzees and eight rhesus monkeys.

They found that the distinct gene expression patterns of the three species can be explained by corresponding changes in genetic and epigenetic regulatory mechanisms that determine when and how a gene's DNA code is transcribed to a messenger RNA (mRNA) molecule.

Dr. Gilad also determined that the epigenetics process known as histone modification also differs in the three species. The presence of histone marks during gene transcription indicates that the process is being prevented or modified.

Go here to see the original:

Humans, chimpanzees and monkeys share DNA but not gene regulatory mechanisms

Tech-Long Water Treatment


Tech-Long Water Treatment Beverage processing
The P ID of Water Treatment System depends on the quality of row water Resource and the usage of water. Generally Water Treatment System including pre-treatment, membrane technology and sterilization technology. System Content Pre-treatment system including multi-media filter, active carbon filter, softener, Iron-Manganese Removal filter, Ultrafiltration, Microfiltration, etc. Membrane technologies including RO membrane, Ion exchange method, The sterilization including Ozone or UV sterilization and reverse osmosis-mixed bed demineralizing system and EDI or CDI treatment. Application #9678; Water for food beverage processing Treated, purified drinking water, mineral water, mineralized water, beverages blending water , beer,liquor, health care products. #9678; Brackish water and sea water desalination #9678; Water for electronic industry, water for washing electronic components such as Integrated circuit, silicon wafer, display tubes, etc.. #9678; Water supply for boilers #9678; Water for pharmaceutical industry #9678; Condense and recycle useful substances from the aqueous solution during the industrial production. #9678; Other pure water, ultra-pure water equipment not mentioned Beverage Processing System including thermal system and sugar dissolving system for hot-filling line and CSD Line. Application The beverage processing system applies to beverage processing for hot filling line and CSD filling line. Hot water system - hot water for sugar dissolving hot water for fruit juice /Concentrate ...From:Amritraj BangeraViews:0 0ratingsTime:06:43More inScience Technology

Go here to see the original:

Tech-Long Water Treatment

Novalis Focused Radiation Therapy | UCLA Pituitary Tumor Program – Video


Novalis Focused Radiation Therapy | UCLA Pituitary Tumor Program
The Pituitary Tumor Program at UCLA is a multi-disciplinary team of health care professionals dedicated to providing state-of-the-art management of pituitary tumors. Learn more at pituitary.ucla.edu or call the Neurosurgery Referral Line at (310) 825-5111.From:UCLAHealthViews:5 0ratingsTime:00:58More inScience Technology

Read this article:

Novalis Focused Radiation Therapy | UCLA Pituitary Tumor Program - Video

UCLA Pituitary Tumor Program Overview – Video


UCLA Pituitary Tumor Program Overview
The Pituitary Tumor Program at UCLA is a multi-disciplinary team of health care professionals dedicated to providing state-of-the-art management of pituitary tumors. Learn more at pituitary.ucla.edu or call the Neurosurgery Referral Line at (310) 825-5111.From:UCLAHealthViews:10 0ratingsTime:03:17More inScience Technology

Read the original:

UCLA Pituitary Tumor Program Overview - Video

Master Program International Health


Master Program International Health Social Management - A student #39;s perspective.mp4
The Master program International Health Social Management prepares its students for the requirements of a future-oriented field of work where an understanding of the links between health care organizations -- charitable and profit-oriented, public and private, national and international -- is essential. The medium-term outlook for graduates of the two-year Master #39;s program is administrative and upperlevel management positions in the health care sector and related fields. Due to the changing health care environment, the demand for qualified persons in this sector is constantly rising. Across the European Union, health systems and health policies are becoming more interconnected than ever before, with more movement of patients and professionals, higher public expectations, and wider diffusion of new medical technologies and techniques. This increased interconnectedness raises many health policy issues, including quality and access in cross-border care -- information requirements for patients, health professionals and policy-makers -- the scope for cooperation in health matters -- and how to reconcile national policies with European obligations in general. Please notice also our innovative double degree or multiple degree option in cooperation with prestigious European universities: http://www.eu-hem.eu Link to the program: http://www.mci.eduFrom:MCIHealthViews:3 0ratingsTime:12:22More inEducation

Originally posted here:

Master Program International Health